{"id":20513,"date":"2023-10-27T09:32:51","date_gmt":"2023-10-27T09:32:51","guid":{"rendered":"https:\/\/clinlabint.com\/?p=20513"},"modified":"2023-10-27T09:33:01","modified_gmt":"2023-10-27T09:33:01","slug":"sartorius-partners-with-sparta-biodiscovery-to-facilitate-launch-of-novel-nanoparticle-analysis-platform","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/sartorius-partners-with-sparta-biodiscovery-to-facilitate-launch-of-novel-nanoparticle-analysis-platform\/","title":{"rendered":"Sartorius partners with SPARTA Biodiscovery to facilitate launch of novel nanoparticle analysis platform"},"content":{"rendered":"<div id='av_section_1'  class='avia-section main_color avia-section-default avia-no-border-styling  avia-bg-style-scroll  avia-builder-el-0  avia-builder-el-no-sibling   container_wrap fullsize' style=' '  ><div class='container' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-20513'><div class='entry-content-wrapper clearfix'>\n<div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding first  avia-builder-el-1  el_before_av_three_fifth  avia-builder-el-first  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><!--Begin ClixTrac.com Banner Code -->\r\n<a href=\"https:\/\/clixtrac.com\/goto\/?311442\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/clixtrac.com\/banner\/311442.jpg\" alt=\"Bio-Rad - Preparing for a Stress-free QC Audit\" title=\"Bio-Rad - Preparing for a Stress-free QC Audit\" border=\"0\" \/><\/a>\r\n<!--End ClixTrac.com Banner Code --><\/p>\n<\/div><\/section><\/div><div class=\"flex_column av_three_fifth  flex_column_div av-zero-column-padding   avia-builder-el-3  el_after_av_one_fifth  el_before_av_one_fifth  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><div style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"clinl-1356334774\"><!--Begin ClixTrac.com Banner Code -->\r\n<a href=\"https:\/\/clixtrac.com\/banner\/click.php?banner=283809\" target=\"_blank\" rel=\"noopener\">\r\n<img decoding=\"async\" src=\"https:\/\/clixtrac.com\/banner\/283809.png\" alt=\"\" title=\"\" border=\"0\"><\/a>\r\n<!--End ClixTrac.com Banner Code --><\/div><\/p>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><header class=\"entry-content-header\"><h1 class=\"post-title entry-title\" itemprop=\"headline\">Sartorius partners with SPARTA Biodiscovery to facilitate launch of novel nanoparticle analysis platform<\/h1><span class=\"post-meta-infos\">\/ <span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/clinlabint.com\/e-news\/\" rel=\"tag\">E-News<\/a>  <\/span><\/span><\/header>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><h3>The life science group Sartorius and UK-based start-up SPARTA Biodiscovery have agreed to partner on SPARTA\u2019s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for bio-pharmaceutical drugs.<\/h3>\n<p class=\"wp-more-tag mce-wp-more\" title=\"Read more...\" data-wp-more=\"more\" data-wp-more-text=\"\" data-mce-placeholder=\"1\"><!--more--><\/p>\n<p>Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells. As part of the cooperation, Sartorius will invest up to \u00a33.5 million in a minority share-holding in SPARTA Biodiscovery through its corporate investment unit Sartorius Ventures.<\/p>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p>\u201cThe SPARTA platform will help customers optimize the design of nanoparticles at an early stage, even before the drug candidates move on to the clinic. We have teamed up to bring additional product commercialization and application expertise to the table to facilitate a swift transitioning from prototype to launch,\u201d said Prof. Dr Oscar-Werner Reif, Head of Corporate Research and CTO at Sartorius.<\/p>\n<p>Dr Jelle Penders, CEO and co-founder of SPARTA Biodiscovery, commented: \u201cOften the challenge in bringing new therapies to life is not the development of new active agents, but safe and robust delivery of such agents into the body, e.g., through nanoparticles. We see an unmet need in R&amp;D, manufacturing, and quality control in analyzing the composition of these nanoformulations. Together with Sartorius, we will be able to bring this technology to customers faster.\u201d<\/p>\n<p>The SPARTA Biodiscovery team spun off from Imperial College London, where it developed the core technology and prototype for the platform in the group of co-founder Professor Molly Stevens FRS, FREng. The SPARTA technology \u2013 Single Particle Automated Raman Trapping Analysis \u2013 uses spectroscopy to analyze populations of individual nanoparticles quickly and automatically at high throughput \u2013 helping to accelerate nanoparticle development and optimize quality control during production.<\/p>\n<\/div><\/section><br \/>\n<div   class='hr hr-default   avia-builder-el-8  el_after_av_textblock  el_before_av_image '><span class='hr-inner ' ><span class='hr-inner-style'><\/span><\/span><\/div><br \/>\n<div  class='avia-image-container  av-styling-    avia-builder-el-9  el_after_av_hr  el_before_av_textblock  avia-align-center '  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\"  ><div class='avia-image-container-inner'><div class='avia-image-overlay-wrap'><img decoding=\"async\" class=\"avia_image\" src=\"https:\/\/clinlabint.com\/wp-content\/uploads\/sites\/2\/2023\/10\/Sartorius_Prof_Dr_Oscar-Werner_Reif_06.jpg\" alt=\"\" title=\"Sartorius_Prof_Dr_Oscar-Werner_Reif_06\" height=\"1280\" width=\"1920\" itemprop=\"thumbnailUrl\"><\/div><\/div><\/div><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p><em><strong>Prof. Dr Oscar-Werner Reif, Sartorius<\/strong><\/em><\/p>\n<\/div><\/section><br \/>\n<div   class='hr hr-default   avia-builder-el-11  el_after_av_textblock  el_before_av_image '><span class='hr-inner ' ><span class='hr-inner-style'><\/span><\/span><\/div><br \/>\n<div  class='avia-image-container  av-styling-    avia-builder-el-12  el_after_av_hr  el_before_av_textblock  avia-align-center '  itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\"  ><div class='avia-image-container-inner'><div class='avia-image-overlay-wrap'><img decoding=\"async\" class=\"avia_image\" src=\"https:\/\/clinlabint.com\/wp-content\/uploads\/sites\/2\/2023\/10\/SPARTA_Jelle_Penders.jpg\" alt=\"\" title=\"Staff photoshoot 15 July 2022.\" height=\"1281\" width=\"1920\" itemprop=\"thumbnailUrl\"><\/div><\/div><\/div><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p><em><strong>Dr Jelle Penders, SPARTA Biodiscovery<\/strong><\/em><\/p>\n<\/div><\/section><br \/>\n<div  class='av-social-sharing-box  avia-builder-el-14  el_after_av_textblock  avia-builder-el-last  av-social-sharing-box-minimal '><div class='av-share-box'><h5 class='av-share-link-description av-no-toc '>Share this<\/h5><ul class='av-share-box-list noLightbox'><li class='av-share-link av-social-link-facebook' ><a target=\"_blank\" aria-label=\"Share on Facebook\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/clinlabint.com\/sartorius-partners-with-sparta-biodiscovery-to-facilitate-launch-of-novel-nanoparticle-analysis-platform\/&#038;t=Sartorius%20partners%20with%20SPARTA%20Biodiscovery%20to%20facilitate%20launch%20of%20novel%20nanoparticle%20analysis%20platform\" aria-hidden=\"false\" data-av_icon=\"\ue8f3\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on Facebook\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Facebook<\/span><\/a><\/li><li class='av-share-link av-social-link-twitter' ><a target=\"_blank\" aria-label=\"Share on Twitter\" href=\"https:\/\/twitter.com\/share?text=Sartorius%20partners%20with%20SPARTA%20Biodiscovery%20to%20facilitate%20launch%20of%20novel%20nanoparticle%20analysis%20platform&#038;url=https:\/\/clinlabint.com\/?p=20513\" aria-hidden=\"false\" data-av_icon=\"\ue8f1\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on Twitter\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Twitter<\/span><\/a><\/li><li class='av-share-link av-social-link-whatsapp' ><a target=\"_blank\" aria-label=\"Share on WhatsApp\" href=\"https:\/\/api.whatsapp.com\/send?text=https:\/\/clinlabint.com\/sartorius-partners-with-sparta-biodiscovery-to-facilitate-launch-of-novel-nanoparticle-analysis-platform\/\" aria-hidden=\"false\" data-av_icon=\"\uf232\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on WhatsApp\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on WhatsApp<\/span><\/a><\/li><li class='av-share-link av-social-link-linkedin' ><a target=\"_blank\" aria-label=\"Share on LinkedIn\" href=\"https:\/\/linkedin.com\/shareArticle?mini=true&#038;title=Sartorius%20partners%20with%20SPARTA%20Biodiscovery%20to%20facilitate%20launch%20of%20novel%20nanoparticle%20analysis%20platform&#038;url=https:\/\/clinlabint.com\/sartorius-partners-with-sparta-biodiscovery-to-facilitate-launch-of-novel-nanoparticle-analysis-platform\/\" aria-hidden=\"false\" data-av_icon=\"\ue8fc\" data-av_iconfont=\"entypo-fontello\" title=\"\" data-avia-related-tooltip=\"Share on LinkedIn\" rel=\"noopener\"><span class='avia_hidden_link_text'>Share on LinkedIn<\/span><\/a><\/li><li class='av-share-link av-social-link-mail' ><a  aria-label=\"Share by Mail\" href='mailto:?subject=Sartorius%20partners%20with%20SPARTA%20Biodiscovery%20to%20facilitate%20launch%20of%20novel%20nanoparticle%20analysis%20platform&#038;body=https:\/\/clinlabint.com\/sartorius-partners-with-sparta-biodiscovery-to-facilitate-launch-of-novel-nanoparticle-analysis-platform\/' aria-hidden='false' data-av_icon='\ue805' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share by Mail'><span class='avia_hidden_link_text'>Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/p><\/div><div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding   avia-builder-el-15  el_after_av_three_fifth  avia-builder-el-last  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The life science group Sartorius and UK-based start-up SPARTA Biodiscovery have agreed to partner on SPARTA\u2019s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for bio-pharmaceutical drugs.<\/p>\n","protected":false},"author":3,"featured_media":20514,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"class_list":["post-20513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-e-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/20513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=20513"}],"version-history":[{"count":2,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/20513\/revisions"}],"predecessor-version":[{"id":20517,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/20513\/revisions\/20517"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/20514"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=20513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=20513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=20513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}